Lippo General Insurance Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Lippo General Insurance Tbk. trades at Rp645 (market cap 1.94T, 300 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Lippo General Insurance Tbk. is far larger — about 18.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| LPGI | SCPI | |
|---|---|---|
Market Cap | 1.94T | 104.4B |
Volume | 300 | — |
Lot | 3 | — |
Turnover | 193K | — |
Average Price | 643.33 | — |
Value | 193K | — |
Indicative Equilibrium Price | 645 | — |
Indicative Equilibrium Volume | 100 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Lippo General Insurance Tbk (the Company) was established and domiciled in Surabaya based on Notarial Deed No. 1 of Adasiah Harahap, S.H., notary in Jakarta, dated September 6, 1963, under the name of PT Asuransi Brawidjaja and was changed to PT Maskapai Asuransi Marga Pusaka based onNotarial Deed No. 46 of Misahardi Wilamarta, S.H., notary in Jakarta, subtitute notary of Adasiah Harahap, S.H., notary in Jakarta.
Read more on LPGI →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →